|

Standard maintenance therapy Clinical Trials

1 actively recruiting trial

Also known as: Cellcept, Imuran

Pipeline

Phase 2: 1

Top Sponsors

  • The University of Hong Kong1

Indications

  • Lupus Nephritis1
  • Lupus1
  • Chronic Kidney Diseases1

Other1 trial

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.